New stock news | Pu'ai Medical's Hong Kong IPO and domestic unlisted shares "Fully Circulated" are filed with the China Securities Regulatory Commission.

On October 29th, the International Cooperation Department of the China Securities Regulatory Commission issued a "Notice on the Overseas Issuance and Listing of Nanjing Pulei Medical Equipment Co., Ltd. and the Full Circulation of Unlisted Shares in China" The company plans to issue no more than 34,500,000 shares of overseas-listed common stock and list on the Hong Kong Stock Exchange. Fourteen shareholders of the company plan to convert a total of 17,576,373 shares of unlisted domestic shares into overseas-listed shares and list them on the Hong Kong Stock Exchange for circulation. The prospectus shows that Pulei Medical focuses on X-ray imaging technology, starting from its initial product, as of April 20, 2025, the product portfolio has expanded to over 100 models, supported by proprietary technologies such as X-ray tube components, high-voltage generators, and 3D imaging technology. The company's product portfolio includes: mobile C-arm X-ray machines, mainly used for moving X-ray fluoroscopy and imaging equipment with a C-arm frame during surgical procedures; digital radiography X-ray machines (DR), a medical radiation imaging device that converts X-ray photon signals into digital images; and DRF digital radiography X-ray machines, a digital gastrointestinal machine. Attachment: Names of "full circulation" shareholders and conversion quantities